Your browser doesn't support javascript.
loading
Identification of V6.51L as a selectivity hotspot in stereoselective A2B adenosine receptor antagonist recognition.
Wang, Xuesong; Jespers, Willem; Prieto-Díaz, Rubén; Majellaro, Maria; IJzerman, Adriaan P; van Westen, Gerard J P; Sotelo, Eddy; Heitman, Laura H; Gutiérrez-de-Terán, Hugo.
Afiliação
  • Wang X; Division of Drug Discovery and Safety, Leiden Academic Centre for Drug Research, Einsteinweg 55, 2333 CC, Leiden, The Netherlands.
  • Jespers W; Division of Drug Discovery and Safety, Leiden Academic Centre for Drug Research, Einsteinweg 55, 2333 CC, Leiden, The Netherlands.
  • Prieto-Díaz R; Department of Cell and Molecular Biology and Science for Life Laboratory, Uppsala University, Box 596, 751 24, Biomedical CenterUppsala, Sweden.
  • Majellaro M; Centro Singular de Investigación en Química Biolóxica Y Materiais Moleculares (CIQUS), Santiago de Compostela, Spain.
  • IJzerman AP; Departamento de Química Orgánica, Facultade de Farmacia, Universidade de Santiago de Compostela, 15782, Santiago de Compostela, Spain.
  • van Westen GJP; Centro Singular de Investigación en Química Biolóxica Y Materiais Moleculares (CIQUS), Santiago de Compostela, Spain.
  • Sotelo E; Departamento de Química Orgánica, Facultade de Farmacia, Universidade de Santiago de Compostela, 15782, Santiago de Compostela, Spain.
  • Heitman LH; Division of Drug Discovery and Safety, Leiden Academic Centre for Drug Research, Einsteinweg 55, 2333 CC, Leiden, The Netherlands.
  • Gutiérrez-de-Terán H; Division of Drug Discovery and Safety, Leiden Academic Centre for Drug Research, Einsteinweg 55, 2333 CC, Leiden, The Netherlands.
Sci Rep ; 11(1): 14171, 2021 07 08.
Article em En | MEDLINE | ID: mdl-34238993
ABSTRACT
The four adenosine receptors (ARs) A1AR, A2AAR, A2BAR, and A3AR are G protein-coupled receptors (GPCRs) for which an exceptional amount of experimental and structural data is available. Still, limited success has been achieved in getting new chemical modulators on the market. As such, there is a clear interest in the design of novel selective chemical entities for this family of receptors. In this work, we investigate the selective recognition of ISAM-140, a recently reported A2BAR reference antagonist. A combination of semipreparative chiral HPLC, circular dichroism and X-ray crystallography was used to separate and unequivocally assign the configuration of each enantiomer. Subsequently affinity evaluation for both A2A and A2B receptors demonstrate the stereospecific and selective recognition of (S)-ISAM140 to the A2BAR. The molecular modeling suggested that the structural determinants of this selectivity profile would be residue V2506.51 in A2BAR, which is a leucine in all other ARs including the closely related A2AAR. This was herein confirmed by radioligand binding assays and rigorous free energy perturbation (FEP) calculations performed on the L249V6.51 mutant A2AAR receptor. Taken together, this study provides further insights in the binding mode of these A2BAR antagonists, paving the way for future ligand optimization.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Substituição de Aminoácidos / Receptor A2B de Adenosina / Antagonistas de Receptores Purinérgicos P1 Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Substituição de Aminoácidos / Receptor A2B de Adenosina / Antagonistas de Receptores Purinérgicos P1 Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article